Arterial Stiffness and Endothelial Function

For physicians

What is measured

An arterial stiffness index derived from cuff-based oscillometric acquisition with pulse wave velocity, together with contour analysis of the digital photoplethysmographic waveform. Endothelial-related markers are assessed from the waveform response and read alongside the insulin and inflammatory results from the laboratory panel.

Why it sits inside a metabolic assessment

Endothelial function is tightly coupled to insulin signaling in the vessel wall, which is why endothelial markers behave as insulin-resistance markers and why they move alongside prothrombotic and pro-inflammatory measures and vascular tone. In a population where metabolic health is rare — 12.2% of American adults met a full definition of optimal metabolic health in the National Health and Nutrition Examination Survey for 2009 to 2016 — so roughly 88% of US adults did not — this is where the earliest measurable vascular consequence appears.

Interpretive notes

• Stiffness indices are strongly age- and blood-pressure-dependent. Interpret against both, not against a single population cut point.
• Acute conditions matter: caffeine, nicotine, a recent meal, cold extremities and recent exercise all shift the measurement.
• The clinically useful application is serial. A stiffness index that has not moved over two years carries information that a first reading cannot.
• Discordance between a normal stiffness index and an abnormal ankle-brachial index is expected — they describe different segments and different properties.

Where it fits

Acquired with the ankle-brachial index, pulse volume recording and digital waveform analysis, and read against the metabolic panel. Interpreting the report.

Evidence and limitations

Written for a reader who wants the literature rather than the summary. Where the evidence is thin we say so and give both sides, and where a claim is mechanistic rather than demonstrated we label it as such.

Mechanism

A compliant aorta stores part of each stroke volume in systole and releases it in diastole, smoothing flow and limiting the pressure that reaches downstream microcirculation. As elastin fragments and collagen accumulates — accelerated by hypertension, hyperglycemia and inflammation — the vessel stiffens, pulse wave velocity rises, and reflected waves return earlier, augmenting central systolic pressure and increasing left ventricular load while transmitting greater pulsatile energy into the kidney, brain and eye.

Endothelial function sits upstream of that process. The endothelium regulates vascular tone, thrombosis and inflammation, and its signaling is tightly coupled to insulin action in the vessel wall — which is why endothelial markers behave as insulin-resistance markers and move alongside prothrombotic and pro-inflammatory measures.

What the evidence shows

The strongest quantitative evidence is for aortic pulse wave velocity. A meta-analysis of 17 longitudinal studies following 15,877 subjects for a mean of 7.7 years found pooled relative risks, comparing high with low aortic pulse wave velocity, of 2.26 (95% CI 1.89 to 2.70) for total cardiovascular events, 2.02 (95% CI 1.68 to 2.42) for cardiovascular mortality and 1.90 (95% CI 1.61 to 2.24) for all-cause mortality. Risk increased in a stepwise, near-linear fashion across tertiles.

The dose-response is quantified: an increase in aortic pulse wave velocity of 1 m/s corresponded to an age-, sex- and risk-factor-adjusted increase of 14% in total cardiovascular events, 15% in cardiovascular mortality and 15% in all-cause mortality. A one standard deviation increase corresponded to increases of 47%, 47% and 42% respectively. Predictive ability was higher in subjects at higher baseline risk — coronary artery disease, renal disease, hypertension — than in the general population.

Limitations of that evidence

• Method matters. The meta-analysis above is of carotid-femoral aortic pulse wave velocity. Cuff-derived stiffness indices are not interchangeable with it, and a risk estimate obtained with one method should not be quoted for another.
• Blood pressure dependence. Stiffness measures are strongly pressure- and age-dependent, so an isolated value without both is not interpretable.
• Acute conditions. Caffeine, nicotine, a recent meal, cold extremities and recent exercise all shift the reading.
• Observational data. These are longitudinal cohorts. Stiffness is a marker of cumulative vascular exposure, and separating it from the exposures that caused it is difficult.
• Endothelial markers are less standardized than pulse wave velocity, with more between-method variation and weaker outcome data.

What remains uncertain

Whether treating stiffness as a target — rather than treating blood pressure, glucose and smoking and observing stiffness follow — independently improves outcomes has not been established. The honest position is that arterial stiffness is a well-validated risk marker with a quantified dose-response and an unproven role as a treatment target. It is used on this site as a marker and as a serial measure of whether conventional risk-factor treatment is working.